Upload
heather-charles
View
238
Download
0
Tags:
Embed Size (px)
Citation preview
Arista Biologicals Inc.
Denise C. GlascockSales & Marketing Manager
Background Founded in 1993 by Dr. John
Colanduoni Established originally to provide
biological reagents to diagnostic kit manufacturers.
Now supplies all necessary components to produce rapid diagnostic assays as well as the technology required.
Mission Statement Our mission is to make available to our
customers, whether they are in the start-up phase or established, the highest quality reagents for the lateral flow industry.
We believe this policy will open the market to people in underdeveloped countries, and will help bring them the level of healthcare that is now only accessible to the more developed countries.
IVD Market & Rapid Assay Market Overview
Arista Biologicals Inc.
History Immunological interactions have been
used for In-Vitro Diagnostic purposes for many years
Started with Agglutination Assays Immunoassays became popular with the
development on EIA and ELISA technology
EIAs and ELISAs are still the backbone of clinical immunodiagnostics
Arista Biologicals Inc.
History Cont… Problem
EIAs and ELISAs require a lot of time, sophisticated equipment and highly trained personnel. The Primary Issue was Cost
Solution Membrane Based Assays
Arista Biologicals Inc.
History Cont… Specific Immunoadsorption
Dipstick Devices Immunoconcentraion Devices
Flow Through Immunochromatography Devices
Lateral Flow
Arista Biologicals Inc.
History Cont… In the mid-1970’s initial Immunoassays on
membranes were developed as variations of Dot Blots. The membrane acted as a solid phase with a surface area for the immobilization of one of the reactants.
The primary application was in research, not clinical diagnostics.
This was the precursor to the Immunoconcentraion/Flow-Through
Arista Biologicals Inc.
History Cont… Specific
Immunoadsorption/Dipstick Devices In the mid-1970’s Dip-Stick tests were
developed for routine chemistry application.
This technology has been adapted for environmental testing.
Arista Biologicals Inc.
History Cont… Immunoconcentration/Flow-Through Devices
In the early-1980’s membranes were first utilized in immunoassay devices in a vertical flow-through configuration that exploited the advantages of using membrane for more than its ability to act as a solid phase for immobilization.
This configuration reduced incubation times by a factor of 10.
Allows for the manufacture of simple, rapid, disposable immunoassay devices that can be used in the home or in other remote testing sites.
Still requires multiple steps.
Arista Biologicals Inc.
History Cont… Immunochromatography/Lateral Flow Devices
In the late-1980’s a second generation of immunoassay devices was developed.
Key to Lateral Flow performance is the manufacture of large nitrocellulose (LPNC) membranes that promotes the lateral flow of fluids enabling the application of various immunoreactants at different locations along a membrane strip.
Enhanced one-step simple, rapid, disposable immunoassay devices that can be used in the home or in other remote testing sites.
Does not require training or experienced personnel. Can easily be used in the home.
Arista Biologicals Inc.
Today’s Market
There are more than 250 commercial tests available for Human Diagnostics and Screening, Veterinary Diagnostics, Agriculture Testing and Environmental Screening.
The Asian market is exhibiting the most rapid growth.
There are over 200 manufacturers of Rapid Test Devices in the world.
Increased competition creating pricing pressure.
Arista Biologicals Inc.
Key Market Drivers
Cost/Labor Reduction Reduced Turn-Around-Time (TAT) Disease Focused Testing Convenience and Simplicity Enhanced Clinical Utility
Arista Biologicals Inc.
Rapid Test Device Market Segments
OTC/Home Testing
Professional POC/Remote Site Testing
Arista Biologicals Inc.
OTC/Home Testing Market
Pregnancy Drugs Of
Abuse Fertility FOBT
Arista Biologicals Inc.
Professional POC Testing
Pregnancy Drugs Of Abuse Infectious Disease FOBT
Arista Biologicals Inc.
Future Market Trends
Increased demand for quantitative tests
Growth Market Segments are Infectious Disease, Drugs-of-Abuse, Veterinary Diagnostics and Agricultural Testing
Arista Biologicals Inc.
Key IVD Growth Assays (Not in order of projected value)
Drugs-of-Abuse Cancer
Screening Osteoporosis Hepatitis B & C HIV
Diabetes Monitoring
Cholesterol/Lipid Panel
Cardiac Monitoring
Saliva Based Tests
Arista Biologicals Inc.
Patents in RTD
Arista Biologicals Inc.
Patents; Our Opinion
In no way do we encourage you to infringe upon the patent rights of other manufacturers of rapid test devices
You have a responsibility to evaluate existing patent rights
This is an area in which you must do your homework
Arista Biologicals Inc.
Patents
Patents; Why are they important?
Obviously it is important not to infringe on other organizations’ patents
The patent literature is one of the best sources of information for this technology
Arista Biologicals Inc.
Patents
Patents; Where can you find them? The Internet, the PTO site (
Http://www.patents.ibm.com) Certain data bases, Dialog, a very
extensive cross-referenced data base that is the best source I know for foreign patents (Derwent file)
Arista Biologicals Inc.
Patents
Patents; Where can you find them? Care should be taken to search for
patents outside the US European Patent Office Site (
Http://www.epo.co.at/epo/) Most country patent offices now have
a web site
Arista Biologicals Inc.
Patents
Patents; What should you do Carefully evaluate the existing patent
literature Early in the process of concept
development, work with your patent attorney
Arista Biologicals Inc.
Patents
Patents; Some solutions Seek a license Practice in a country not covered by
the patent Invent around critical issues
Arista Biologicals Inc.